PAVmed (PAVM) Cash from Operations (2015 - 2025)

PAVmed's Cash from Operations history runs 11 years deep, the most recent figure standing at 1500000.0 for Q4 2025.

• On a quarterly basis, Cash from Operations fell 1695.74% year-over-year to 1500000.0 in Q4 2025; TTM through Dec 2025 was 5200000.0, a 85.77% increase from a year earlier, with the FY2025 full-year figure at 5200000.0, up 84.5% from the prior year.
• Cash from Operations fell to 1500000.0 in Q4 2025 per PAVM's latest filing, from 900000.0 in the prior quarter.
• Across five years, Cash from Operations topped out at 94000.0 in Q4 2024 and bottomed at 22558000.0 in Q2 2022.
• The 5-year median for Cash from Operations is 11656000.0 (2024), against an average of 10183315.79.
• Across the five-year window, Cash from Operations jumped 100.79% in 2024 and tumbled 1695.74% in 2025, its largest moves.
• Year by year, Cash from Operations stood at 16777000.0 in 2021, then retreated by 0.27% to 16823000.0 in 2022, then gained by 29.42% to 11874000.0 in 2023, then soared by 100.79% to 94000.0 in 2024, then tumbled by 1695.74% to 1500000.0 in 2025.
• Per Business Quant, the three latest PAVM Cash from Operations figures stand at 1500000.0 (Q4 2025), 900000.0 (Q3 2025), and 1219000.0 (Q2 2025).